Nine cosmetic products found to contain mercury, hydroquinone - Health DG

FB KKM

KUALA LUMPUR, July 15  -- The Health Ministry has urged the public against using and buying nine cosmetic products that have been found to contain scheduled poison, namely mercury and hydroquinone, which can be harmful to health.

Health director-general Datuk Dr Noor Hisham Abdullah, in a statement today, said that the products are Deeja Cosmetics Laika Cream (mercury), Dejaa Cosmetics Zulai Cream (hydroquinone), Deeja Cosmetics Yus Cream (hydroquinone), and Dnars Luvee Cream (Normal & Sensitive) (hydroquinone). 

Others are Dnars Gold Lifting Serum (Night) (mercury), Sparkle Beauty Cream (hydroquinone, tretinoin & betamethasone 17-valerate), Sparkle Sun Day Cream (mercury), Qeziger Age-locking Recharging Spot A.M Cream (mercury), and MS Skinz Night Cream (mercury).

He said that the ministry through the senior director of Pharmaceutical Services had cancelled the products notification, and they are no longer allowed to be sold in the country.

Products containing hydroquinone, tretinoin and betamethasone 17-valerate must be registered under the Drug Control Authority and could only be used on the advice of health professionals, he said.

“The use of the products without the supervision of health professionals can cause side effects,” he added.


FB KKM

As such, sellers and distributors of these cosmetic products should immediately stop the sales and distribution of these products.

 Dr Noor Hisham stressed that the sale and distribution of these cosmetic products violated the Control Of Drugs And Cosmetics Regulations 1984 and those found guilty could face stiff penalties. 

 He also advised members of the public who have been using the products to immediately stop and seek advice from health professionals if they experience any discomfort or adverse effects.

 -- BERNAMA

 

 




For more information click here

HealthEdge


EXCLUSIVE

UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad

KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.

ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.

Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.

read more ››

IN FOCUS

UMSC: Pain Management


In Focus : UMSC Raya Open House 2018

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 1

In Focus : UMSC - Fatty Liver, The Silent Epidemic Part 2